SEC Form 4 · accession 0000882104-16-000188
PDL BIOPHARMA, INC. · PDLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter S Garcia
Officer — Vice President, CFO
Period of report
Aug 9, 2016
Accepted (ET)
Aug 10, 2016 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882104
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Aug 9, 2016 | P | 5,000 | $2.994 | A | 232,092 | D | |
| Common stock | Aug 9, 2016 | P | 5,000 | $2.996 | A | 237,092 | D |
Table II — derivative securities
No Table II lines on this filing.